Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Signs and Symptoms-Clinical Findings
- Asthma
- Anatomy
- Allergy & Immunology
- Plastic Surgery
- Biochemistry and Biostatistics
- Genetics
- Orthopedics & Rheumatology
Abstract
Citation: Clin Case Rep Int. 2022;6(1):1344.DOI: 10.25107/2638-4558.1344
The Development of De novo Acute Tubulointerstitial Nephritis and Membranous Nephropathy Following Inactivated COVID-19 Vaccine: Causal or Casual?
Zhao Y, Zhang L, Wang G, Guan J and Pai P
Department of Microbiology, The University of Hong Kong-Faculty of Medicine, China
Department of Nephrology, The University of Hong Kong-Shenzhen Hospital, China
Department of Pathology, The University of Hong Kong-Shenzhen Hospital, China
Department of Medicine, The University of Hong Kong-Faculty of Medicine, China
Both the authors contributed equally to this work
PDF Full Text Case Report | Open Access
Abstract:
Acute tubulointerstitial nephritis is a common cause of hospital acquired acute kidney injury as part of a drug reaction, for instance after β-lactam antibiotics. Different types of COVID-19 vaccineassociated kidney diseases have been reported mostly following mRNA vaccine. The underlying mechanism remains unclear. Recently we treated 3 patients who developed acute tubulointerstitial nephritis and membranous nephropathy following COVID-2019 inactivated vaccine. We wish to share with others these potentially rare conditions and offer our experience in treatment.
Keywords:
Coronavirus disease 2019; Inactivated vaccine; Membranous nephropathy; Acute tubulointerstitial nephritis
Cite the Article:
Zhao Y, Zhang L, Wang G, Guan J, Pai P. The Development of De novo Acute Tubulointerstitial Nephritis and Membranous Nephropathy Following Inactivated COVID-19 Vaccine: Causal or Casual?. Clin Case Rep Int. 2022; 6: 1344.